173 related articles for article (PubMed ID: 8132806)
1. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.
Noorduyn LA; de Bruin PC; van Heerde P; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
J Clin Pathol; 1994 Jan; 47(1):33-7. PubMed ID: 8132806
[TBL] [Abstract][Full Text] [Related]
2. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Romaguera JE; Garcia-Foncillas J; Cabanillas F
Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
[TBL] [Abstract][Full Text] [Related]
3. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
5. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
6. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
8. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma.
Arber DA; Sun LH; Weiss LM
Hum Pathol; 1996 Jun; 27(6):590-4. PubMed ID: 8666370
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
10. CD30 (Ki-1) expression in adult T-cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics.
Takeshita M; Akamatsu M; Ohshima K; Kobari S; Kikuchi M; Suzumiya J; Uike N; Okamura T
Histopathology; 1995 Jun; 26(6):539-46. PubMed ID: 7665144
[TBL] [Abstract][Full Text] [Related]
11. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE; Berard CW; Shuster JJ; Link MP; Pick TE; Murphy SB
J Clin Oncol; 1995 Aug; 13(8):2023-32. PubMed ID: 7636544
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of CD30 Expression in Aggressive B-Cell Lymphomas.
Malysz J; Erdman P; Klapper J; Zhu J; Creer M; Bayerl MG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):429-33. PubMed ID: 27521276
[TBL] [Abstract][Full Text] [Related]
13. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
[TBL] [Abstract][Full Text] [Related]
14. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
16. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
Falini B; Pileri S; Stein H; Dieneman D; Dallenbach F; Delsol G; Minelli O; Poggi S; Martelli MF; Pallesen G
Hum Pathol; 1990 Jun; 21(6):624-9. PubMed ID: 1693592
[TBL] [Abstract][Full Text] [Related]
17. CD30 antigen in non-Hodgkin's lymphoma.
Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
[TBL] [Abstract][Full Text] [Related]
18. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features.
Kinney MC; Glick AD; Stein H; Collins RD
Am J Surg Pathol; 1990 Nov; 14(11):1047-60. PubMed ID: 2173429
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
